COMBINATION THERAPY OF AN AFUCOSYLATED CD20 ANTIBODY WITH BENDAMUSTINE

• 收藏
• 分享

专利权人:

ROCHE GLYCART AG

发明人:

HERTING FRANK,KLEIN CHRISTIAN

申请号：

ZA201200830

公开号：

ZA201200830B

申请日:

2012.02.02

申请国别(地区):

ZA

年份:

2012

代理人:

摘要：

The present invention is directed to the combination therapy of an afucosylated anti-CD20 antibody with bendamustine for the treatment of cancer, especially to the combination therapy of CD20 expressing cancers with an afucosylated humanized B-Ly1 antibody and bendamustine.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/